Royal DSM And Groupe Sebbin Partner To Provide Treatment Options For Breast Reconstruction And Aesthetic Plastic Surgery

EXTON, Pa.--(BUSINESS WIRE)--DSM, a global leader in biomedical materials science and regenerative medicine, today announced a long-term partnership with Groupe Sebbin, a leading manufacturer of breast implants for plastic and reconstructive surgery. Groupe Sebbin will market and distribute DSM’s Meso BioMatrix® Acellular Peritoneum Matrix in Europe and Latin America.

The Meso BioMatrix® Acellular Peritoneum Matrix is the newest addition to a family of extracellular matrix devices processed using DSM’s proprietary OPTRIX™ manufacturing process. There are estimated to be more than 1.7 million new cases of breast cancer reported each year throughout the world. With the increased attention on therapeutic and preventative treatments, as well as recent advance in surgical intervention procedures for managing breast cancer, many women are being offered and opting for breast reconstruction as an aid to restoring a sense of well-being. Designed and developed by DSM, Meso BioMatrix® Acellular Peritoneum Matrix is a surgical mesh that provides easy handling for surgeons with the strength necessary to reinforce soft tissue in breast reconstruction procedures.

Hey, check out all the engineering jobs. Post your resume today!

Back to news